The Treatment Role of Anti-aggregants and Anti-coagulants in Radial Artery Occlusion after Transradial Coronary Angiography

Creative Commons License

Nadir A., Uluganyan M.

BEZMIALEM SCIENCE, vol.11, no.3, pp.315-320, 2023 (ESCI)

  • Publication Type: Article / Article
  • Volume: 11 Issue: 3
  • Publication Date: 2023
  • Doi Number: 10.14235/bas.galenos.2023.97752
  • Journal Indexes: Emerging Sources Citation Index (ESCI)
  • Page Numbers: pp.315-320
  • Bezmialem Vakıf University Affiliated: Yes


Objective: The transradial approach (TRA) has been widely used

for coronary procedures. The rate of complications such as bleeding,

hematoma and pseudoaneurysm is reduced with TRA. The purpose

of this study is to search the treatment role of anti-aggregants and

low molecular weight heparins (LMWH) in situation of radial

artery occlusion (RAO).

Methods: A total of 239 patients (140 men, 58.6%) were included.

Of the patients 159 (66.5%) were elective, and 80 (33.5%) had

acute coronary syndrome. When RAO was detected, patients were

treated with 2 weeks of LMWH.

Results: In 23 (9.6%) of 239 patients, RAO was observed. From

the 23 patients with RAO, 12 (52.8%) were using anti-aggregants,

and the remaining 11 (47.8%) did not use. In terms of RAO, a

statistically significant difference was observed between antiaggregant

users and non-users (p<0.001). In the group using antiaggregants

and LMWH a statistically significant improvement

was observed in the radial flow compared with the group treated

withLMWH alone (p<0.001).

Conclusion: In the present study, we showed that the addition of

anti-aggregants to anti-coagulants decreased RAO rate, declined the

symptoms of RAO, also potentiated the effects of anti-coagulants

and resulted in better recanalization rate of RAO

Keywords: Transradial angiography, radial artery occlusion, low

molecular weight heparin, anti-aggregant